Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer 13-11-2024, 22:57

Leasys and Free2move Lease Consolidation: New Top 2-03-2023, 14:18

Bakery Processing Equipment Market Size Expected to Rise 1-03-2023, 19:55